Notice of Annual General Meeting in Medistim ASA

10 Apr 2025 09:54 CEST

(Oslo, 10th of April 2025) Medistim ASA (OSE: MEDI), a niche market leader
within ultrasound technology with headquarters in Norway, that develops and
commercializes medical equipment for use within cardiac, vascular and transplant
surgery, announces the Annual General Meeting for the company.

The Annual General Meeting will take place on the 8th of May 2025 at 10.00
and is held at Medistim’s offices at Økernveien 94 in Oslo. Attached are the
agenda for the meeting, the voting form and the annual report for 2024. It is
possible to give proxy with and without voting instructions. By using a proxy
with voting instructions, the shareholders will vote on the specific issues
without personal attendance. For further information on the use of proxy, see
general information at the bottom of the notice and enclosed proxy forms.

Attached is also the annual report for 2024 for Medistim ASA in PDF format and
in ESEF format. The report is also available on the company web site:
www.medistim.com.

About Medistim:
Medistim was established in 1984 and has a track record of profitable growth
over the past >15 years. The company is a pioneer within its segment, and
continues to invest in new product development. Medistim has wholly owned
subsidiaries with sales organizations in the USA, Canada, China, Germany, UK,
Spain, Denmark, Sweden and Norway, in addition to the about 60 distributors in
Europe, Asia, Middle East, Africa, Canada and South America. For more
information, visit the Medistim home page: www.Medistim.com
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act (Verdipapirhandelloven).

For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com

More information:
Access the news on Oslo Bors NewsWeb site

643408_Annual Report 2024-FINAL-08.04.2024.pdf
643408_Notice of ordinary general meeting Medistim 2025.pdf
643408_5967007LIEEXZXJOX483-2024-12-31-en.zip